Question of the Week

How Much Did US Insurers Waste on Ivermectin for COVID?

BU Today Season 1 Episode 11
Audio Player
00:00
00:00 | 12:04

Rena Conti, a Questrom School of Business associate professor of markets, public policy, and law, studied insurance claims and reimbursements data and found payments towards ivermectin for COVID-19, plugged by right-wing media despite its unproven efficacy, may have topped $130 million last year. 

News clips from here and here